Cardiovascular Drugs and Therapy, 0920-3206

Journal

View graph of relations

Related Publications
  1. Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial

    Liu, L. C. Y., Valente, M. A. E., Postmus, D., O'Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G. F., Givertz, M. M., Bloomfield, D. M., van Veldhuisen, D. J., Hillege, H. L., van der Meer, P. & Voors, A. A., Jun-2017, In : Cardiovascular Drugs and Therapy. 31, 3, p. 281-293 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Chronic Metformin Treatment is Associated with Reduced Myocardial Infarct Size in Diabetic Patients with ST-segment Elevation Myocardial Infarction

    Lexis, C. P. H., Wieringa, W. G., Hiemstra, B., van Deursen, V. M., Lipsic, E., van der Harst, P., van Veldhuisen, D. J. & van der Horst, I. C. C., Apr-2014, In : Cardiovascular Drugs and Therapy. 28, 2, p. 163-171 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Galectin-3: A Modifiable Risk Factor in Heart Failure

    de Boer, R. A., van der Velde, A. R., Mueller, C., van Veldhuisen, D. J., Anker, S. D., Peacock, W. F., Adams, K. F. & Maisel, A., Jun-2014, In : Cardiovascular Drugs and Therapy. 28, 3, p. 237-246 10 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

View all (42) »

ID: 865874